Roche’s Virtual Event following Angiogenesis 2021

Roche has hosted a virtual event on Tuesday, 16th February 2021.


  • Welcome
    Karl Mahler, Head of Investor Relations and Roche Group Planning
  • Ophthalmology Strategy Update
    Atul Dandekar, Vice President and Global Franchise Head of Ophthalmology Product Strategy
  • Ophthalmology Pipeline Update
    Christopher Brittain, Vice President and Global Head of Ophthalmology Product Development
  • Faricimab in DME and nAMD – Phase III results
    Nancy Holekamp, M.D., Retina Specialist and Clinical Investigator
  • Q&A

Please register to access the webcast replay.*

*Privacy Notice

* Mandatory


The registration form for the webcast is not available.


Please come back 30 minutes before the webcast start date and fill in the registration form.